In CRC, PRMT1‐mediated methylation of phosphoglycerate kinase 1 (PGK1) augments its ERK‐mediated phosphorylation, which activates downstream signaling to drive glycolysis and carcinogenesis [72]. Here, PRMT1 is linked to colorectal carcinoma.